SCHEMBL2652831

SCHEMBL2652831

COC(=O)C1(c2ccc(S)cc2C2CCCC2)CC1

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PTGDR2 Q9Y5Y4 6/20 0.35
▸ PTGDR Q13258 3/20 0.35
▸ SOD1 P00441 1/20 0.35
▸ MAPT P10636 3/20 0.33
▸ CYP3A4 P08684 2/20 0.31
▸ HRH3 Q9Y5N1 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ ALOX15 P16050 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ USP2 O75604 1/20 0.31
▸ TP53 P04637 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ PDE4A P27815 1/20 0.31
▸ PDE4B Q07343 1/20 0.31
▸ PDE4C Q08493 1/20 0.31
▸ PDE4D Q08499 1/20 0.31
▸ CYP1B1 Q16678 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2654649 0.99 PTGDR2 (0.37) PTGDR2PTGDRSOD1MAPTCYP3A4
SCHEMBL2653194 0.83 CYP3A4 (0.39) PTGDR2PTGDRCYP3A4
SCHEMBL2653490 0.82 CYP3A4 (0.41) PTGDR2PTGDRMAPTCYP3A4MEN1
SCHEMBL2655032 0.81 HPGD (0.43) PTGDR2PTGDRSOD1MAPTCYP3A4
SCHEMBL2654132 0.80 PTGS2 (0.41) PTGDR2PTGDRALDH1A1MEN1KMT2A
SCHEMBL2655512 0.71 PTGDR2 (0.55) PTGDR2MAPTCYP3A4MEN1KMT2A
SCHEMBL4678779 0.69 HSD11B1 (0.40) HRH3ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL31045579 0.68 ALOX5AP (0.36) —
SCHEMBL31045604 0.68 PDE4B (0.44) PDE4APDE4BPDE4CPDE4D
SCHEMBL1599280 0.67 SMN1; SMN2 (0.43) CYP3A4ALDH1A1MEN1TP53KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1585739-A1 SUBSTITUTED ARYLCYCLOPROPYLACETAMIDES AS GLUCOKINASE ACTIVATORS ELI LILLY AND COMPANY (US) 2005-10-19 — — EP disclosed
WO-2004063179-A1 SUBSTITUTED ARYLCYCLOPROPYLACETAMIDES AS GLUCOKINASE ACTIVATORS ELI LILLY AND COMPANY (US) 2004-07-29 — — WO disclosed
Send feedback